Gregory E. Deavens Honored: Named Chairman of Hartford HealthCare Board

Gregory E. Deavens was named chairman of the Hartford HealthCare Board of Directors on June 16, 2020.

As executive vice president, chief financial officer, and treasurer of Independence Health Group, Gregory E. Deavens is responsible for all financial functions for Independence Health Group and its subsidiaries. He also plays a key role in strategic planning for the organization.

In nominating Deavens, Hartford HealthCare president and chief executive officer Jeffrey A. Flaks praised Deavens as a person of great integrity, a bright and committed leader who has made significant contributions to the financial stability of Hartford HealthCare during his seven years of service as a board member, including prior service as vice chair.

“I have always valued Greg’s expertise, passion and vision and I am excited to partner with him to continue Hartford HealthCare’s growth as the premiere healthcare system in our region,” Flaks said.

“Greg brings strong strategic planning and leadership skills to the role, as well as tremendous vision. He shares my passion for culture, for building a true system-of-care that is a model for the nation. Together, we are committed to building a more diverse and more equitable health system.”

Deavens succeeds David Hess, whose term as chairman ended. Hess will remain a member of the Board of Directors.

“I am honored to accept the very important role as chairman of the Hartford HealthCare Board and I am grateful to David Hess for his leadership and continued support,” Deavens said. “We have an ambitious path ahead of us, as together, we transform health care in Connecticut and beyond, with a clear focus on the Hartford HealthCare mission to improve the health and healing of the people and communities it serves. I am also encouraged by and share Hartford HealthCare’s commitment to eliminating health disparities in underserved communities.”

Before joining Independence Health Group in January 2017, Deavens was senior vice president and corporate controller at MassMutual Financial Group. Previously, he served as senior vice president and chief financial officer for MassMutual’s U.S. Insurance Group. His earlier experience includes financial leadership roles with New York Life Insurance Company, CIGNA, GE Capital, and PriceWaterhouse.

In addition to his leadership on the HHC board, Deavens serves on the board of directors for The Executive Leadership Council, the African American Museum in Philadelphia, and BCS Financial. He is also a member of the American Institute of Certified Public Accountants and the National Association of Corporate Directors.

Deavens holds a Bachelor of Science degree in Accounting from the Florida A&M University School of Business and Industry. He and his wife, Beverly, have three grown children.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.